Sontra Medical Corporation owns ultrasound and skin permeation technology and is developing a non-invasive CTGM device for diabetes care.
Industry
Sector :
Subsector :
Keywords :
Company Type
For Profit
IPO status
Private
Description
Sontra Medical Corporation specializes in ultrasound and skin permeation technology for therapeutic and diagnostic purposes. They are currently working on a non-invasive CTGM device that can be used in both home and hospital settings for diabetes management. The device utilizes their FDA-approved SonoPrep ultrasound-mediated skin permeation system.